Friday, November 13, 2009

More on Pfizer's Pull Out From New London . . .

From the New York Times, and at the Times' Room For Debate blog.

Also, Tim Iglesias left this excellent comment to the last post on this subject:

In all of the analysis and judgment cited concerning the failure of the New London redevelopment project there is one important piece that is left out: the role of the litigation to stop the project. It may be that the litigation had little actual impact and that the project would have collapsed and failed completely independently of the opposition. However, anyone who has worked with real estate development knows that litigation alone can sometimes kill a project--particularly litigation of the extent and nature in this case. I would feel more comfortable with these analyses and judgments if the potential role of litigation had at least been considered as a contributing factor to the failure. Instead, the folks who brought the litigation and supported it argue as if it that part never existed.

Ben Barros

[Comments are held for approval, so there will be some delay in posting]

Takings | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference More on Pfizer's Pull Out From New London . . .:


Post a comment